228 related articles for article (PubMed ID: 21793029)
1. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.
Lee HY; Birkenfeld AL; Jornayvaz FR; Jurczak MJ; Kanda S; Popov V; Frederick DW; Zhang D; Guigni B; Bharadwaj KG; Choi CS; Goldberg IJ; Park JH; Petersen KF; Samuel VT; Shulman GI
Hepatology; 2011 Nov; 54(5):1650-60. PubMed ID: 21793029
[TBL] [Abstract][Full Text] [Related]
2. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
[TBL] [Abstract][Full Text] [Related]
4. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
5. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice.
Karavia EA; Papachristou DJ; Liopeta K; Triantaphyllidou IE; Dimitrakopoulos O; Kypreos KE
Mol Med; 2012 Sep; 18(1):901-12. PubMed ID: 22576368
[TBL] [Abstract][Full Text] [Related]
7. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice.
Toye AA; Dumas ME; Blancher C; Rothwell AR; Fearnside JF; Wilder SP; Bihoreau MT; Cloarec O; Azzouzi I; Young S; Barton RH; Holmes E; McCarthy MI; Tatoud R; Nicholson JK; Scott J; Gauguier D
Diabetologia; 2007 Sep; 50(9):1867-1879. PubMed ID: 17618414
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
9. FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.
Kim DH; Lee S; Noh SG; Lee J; Chung HY
Aging (Albany NY); 2024 Mar; 16(5):4095-4115. PubMed ID: 38441531
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
11. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
12. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
Kozlitina J; Boerwinkle E; Cohen JC; Hobbs HH
Hepatology; 2011 Feb; 53(2):467-74. PubMed ID: 21274868
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.
Duivenvoorden I; Teusink B; Rensen PC; Romijn JA; Havekes LM; Voshol PJ
Diabetes; 2005 Mar; 54(3):664-71. PubMed ID: 15734841
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
16. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content.
Camporez JPG; Kanda S; Petersen MC; Jornayvaz FR; Samuel VT; Bhanot S; Petersen KF; Jurczak MJ; Shulman GI
J Lipid Res; 2015 Mar; 56(3):526-536. PubMed ID: 25548259
[TBL] [Abstract][Full Text] [Related]
17.
Xu QY; Li H; Cao HX; Pan Q; Fan JG
Biomed Res Int; 2020; 2020():8869674. PubMed ID: 33294458
[TBL] [Abstract][Full Text] [Related]
18. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.
Zhu L; Brown WC; Cai Q; Krust A; Chambon P; McGuinness OP; Stafford JM
Diabetes; 2013 Feb; 62(2):424-34. PubMed ID: 22966069
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance.
Muurling M; van den Hoek AM; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ
J Lipid Res; 2004 Jan; 45(1):9-16. PubMed ID: 14523051
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
